Interchange Capital Partners LLC Buys 25 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Interchange Capital Partners LLC lifted its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 1.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,310 shares of the biotechnology company’s stock after buying an additional 25 shares during the quarter. Interchange Capital Partners LLC’s holdings in Axon Enterprise were worth $779,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in the stock. Groupama Asset Managment purchased a new stake in shares of Axon Enterprise during the third quarter worth about $200,000. Massachusetts Financial Services Co. MA purchased a new stake in shares of Axon Enterprise during the third quarter worth about $120,553,000. Vanguard Group Inc. grew its position in shares of Axon Enterprise by 3.4% during the fourth quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company’s stock worth $5,019,886,000 after purchasing an additional 275,959 shares in the last quarter. Proficio Capital Partners LLC purchased a new stake in shares of Axon Enterprise during the fourth quarter worth about $78,414,000. Finally, Westfield Capital Management Co. LP grew its position in shares of Axon Enterprise by 12.2% during the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after purchasing an additional 127,769 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Trading Up 0.3 %

Shares of NASDAQ:AXON opened at $560.00 on Monday. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $715.99. The business’s fifty day simple moving average is $591.90 and its 200-day simple moving average is $543.57. The company has a market capitalization of $42.91 billion, a PE ratio of 144.70, a P/E/G ratio of 5.17 and a beta of 1.12. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Wall Street Analyst Weigh In

Several research firms have weighed in on AXON. TD Cowen began coverage on Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target for the company. Robert W. Baird raised their price target on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Barclays restated a “hold” rating on shares of Axon Enterprise in a report on Monday, March 10th. JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Finally, The Goldman Sachs Group lifted their target price on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $604.67.

Insider Buying and Selling

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. The trade was a 6.10 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Jeri Williams sold 307 shares of the business’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now owns 1,627 shares in the company, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 6.10% of the stock is owned by company insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.